Find and Pitch Jounalists, Get Your Story Covered

Tags: Celltrion subcutaneous infliximab inflammatory bowel disease infliximab infection

	Profile	Recent Articles on Subject
1	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies - 6 days ago Mirikizumab Effective in Crohn's Disease After Initial Standard Therapy Failure - 22 days ago Risankizumab Beats Ustekinumab for Previously Treated Crohn's - 10 months ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma - 13 days ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 3 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 3 months ago New First-Line Option for Pancreatic Cancer Approved - 10 months ago Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - about 1 year ago Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events - 30 days ago Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 3 months ago FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 3 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 6 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 9 months ago FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications - 10 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 10 months ago FDA Approves Adalimumab-ryvk as Interchangeable Biosimilar for Humira - 10 months ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - 11 months ago Biosimilar SB8 Is Comparable to Bevacizumab for Non–Small Cell Lung Cancer - 11 months ago Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab - 11 months ago Study: Biosimilarities Found Between Yusimry and Humira for Immune, Rheumatic Conditions - 12 months ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - about 1 year ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - about 1 year ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - about 1 year ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda - about 1 month ago Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs - 3 months ago
5	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Novel Anti-IgG Drug Hits Mark in Sjogren's Patients - about 1 month ago Medicare Lags, Medicaid Leads for Biosimilar Uptake - 5 months ago Study Confirms: No Great Options for Treating VEXAS - 7 months ago Novel Drug OK'd for Ulcerative Colitis - about 1 year ago
6	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - about 1 month ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 12 months ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - about 1 year ago New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks - about 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - about 1 year ago
7	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	SC vs IV Administration Methods - about 2 months ago
8	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - about 2 months ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 5 months ago
9	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker - 2 months ago Subcutaneous Alzheimer's Drug May Be on the Horizon - about 1 year ago
10	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Celltrion unveils promising dose escalation results for subcutaneous infliximab - 2 months ago Amgen’s trial brings new hope for IgG4-RD patients - 7 months ago

Journalists covering subcutaneous infliximab